Retraction
Metformin inhibits the proliferation of benign prostatic epithelial cells
Paper Information
Record ID:
64888
Author(s):
Publication Date:
March 02, 2017
Retraction Date:
October 09, 2024
(1.1 year years ago)
Subjects:
Institutions:
- Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
- Department of Urology, Wuhan Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
- Shanghai Children 's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China
Countries:
Article Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0312101Citations (27)
27
Total Citations2
Post-Retraction(7.4%)
24
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
265
Days since retraction (latest)
TNF-α modulates cell proliferation via SOX4/TGF-β/Smad signaling in benign prostatic hyperplasia
Jinze Li, Bo Chen, Yin Huang et al. (17 authors)
Cell Death and Disease
Open Access
Published: Jul 2025
265 days after retraction
Oral glucose-lowering drugs and long-term risk of benign prostatic hyperplasia
S. N. Volkov, Р. К. Михеев, O. R. Grigoryan et al. (6 authors)
Consilium Medicum
Open Access
Published: Dec 2024
70 days after retraction
Retraction: Metformin inhibits the proliferation of benign prostatic epithelial cells
Unknown Authors
PLoS ONE
Open Access
Published: Oct 2024
Same day as retraction
Correction: Metformin inhibits the proliferation of benign prostatic epithelial cells
Zongwei Wang, Xingyuan Xiao, Rongbin Ge et al. (7 authors)
PLoS ONE
Open Access
Published: Dec 2023
1 citation
1 citation
302 days before retraction
Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
Young‐Jin Choi, Meiqi Fan, Nishala Erandi Wedamulla et al. (5 authors)
Deleted Journal
Open Access
Published: Nov 2023
4 citations
4 citations
341 days before retraction
Metformin: A promising clinical therapeutical approach for BPH treatment via inhibiting dysregulated steroid hormones-induced prostatic epithelial cells proliferation
Tingting Yang, Jiayu Yuan, Yuting Peng et al. (17 authors)
Journal of Pharmaceutical Analysis
Open Access
Published: Aug 2023
6 citations
6 citations
414 days before retraction
BPH Patofizyolojisi
Ender Cem Bulut, Ali Atan
Androloji Bülteni
Open Access
Published: Jan 2023
647 days before retraction
Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia
Lotta H. Nygård, Kirsi Talala, Kimmo Taari et al. (6 authors)
The Prostate
Published: Nov 2022
4 citations
4 citations
706 days before retraction
Co-delivery of sorafenib and metformin from amphiphilic polypeptide-based micelles for colon cancer treatment
Xiaohui Zhang, Lanqing Cao, Guangmeng Xu et al. (6 authors)
Frontiers in Medicine
Open Access
Published: Oct 2022
6 citations
6 citations
729 days before retraction
Tamsulosin alters the pharmacokinetics of metformin via inhibition of renal multidrug and toxin extrusion protein 1 and organic cation transporter 2 in rats
Abdulaziz Ahmed A. Saad, Fan Zhang, Moath Refat et al. (9 authors)
Journal of Pharmaceutical and Biomedical Analysis
Published: Feb 2022
5 citations
5 citations
966 days before retraction
A new contribution for an old drug: Prospect of metformin in colorectal oncotherapy
Shangze Jiang, Qingjun Lu
Journal of Cancer Research and Therapeutics
Open Access
Published: Dec 2021
7 citations
7 citations
1043 days before retraction
Metformin attenuates the epithelial-mesenchymal transition of lens epithelial cells through the AMPK/TGF-β/Smad2/3 signalling pathway
Ling Wang, Ye Tian, Zhiqun Shang et al. (6 authors)
Experimental Eye Research
Published: Sep 2021
12 citations
12 citations
1125 days before retraction
The Effect of Metformin on Male Reproductive Function and Prostate: An Updated Review
Chin‐Hsiao Tseng
The World Journal of Men s Health
Open Access
Published: Mar 2021
29 citations
29 citations
1303 days before retraction
Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study
Mette Nørgaard, Bianka Darvalics, Reimar W. Thomsen
BMJ Open
Open Access
Published: Dec 2020
2 citations
2 citations
1408 days before retraction
Benign prostatic hyperplasia – what do we know?
Conor M. Devlin, Matthew Simms, Norman J. Maitland
BJU International
Open Access
Published: Sep 2020
194 citations
194 citations
1486 days before retraction
Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial‐mesenchymal transition and anoikis resistance
Tao Li, Ying Yu, Yarong Song et al. (8 authors)
The FASEB Journal
Published: May 2020
42 citations
42 citations
1612 days before retraction
Cyclopamine functions as a suppressor of benign prostatic hyperplasia by inhibiting epithelial and stromal cell proliferation via suppression of the Hedgehog signaling pathway
Yifeng Yuan, Wen‐Xiong Zhu, Tao Liu et al. (8 authors)
International Journal of Molecular Medicine
Open Access
Published: Apr 2020
14 citations
14 citations
1645 days before retraction
Profile of Diabetes Mellitus in Benign Protate Hyperplation’s Patients with Urinary Retention in Dr. Soetomo 2016
Ahmad Zaidan Ni'am Abu Adha, Reny I’tishom, Fikri Rizaldi et al. (4 authors)
JUXTA Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
Open Access
Published: Aug 2019
2 citations
2 citations
1867 days before retraction
Paper citing Metformin inhibits the proliferation of benign pro...
Unknown Authors
Unknown Journal
Published: Jul 2019
1909 days before retraction
The preventive effect of metformin on progression of benign prostate hyperplasia: A nationwide population-based cohort study in Korea
Yehee Hong, Sanghun Lee, Sungho Won
PLoS ONE
Open Access
Published: Jul 2019
13 citations
13 citations
1909 days before retraction
Una visión integral del cáncer (II). Campos de estudio y biomarcadores emergentes
Rosa Noguera, Rebeca Burgos‐Panadero, Esther Gamero‐Sandemetrio et al. (5 authors)
Revista Española de Patología
Published: Jun 2019
4 citations
4 citations
1947 days before retraction
Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
Yu‐Jui Kuo, Fung‐Chang Sung, Po‐Fan Hsieh et al. (6 authors)
Cancer Medicine
Open Access
Published: Apr 2019
34 citations
34 citations
2010 days before retraction
Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement
Hung‐Jen Shih, Pei‐Shan Tsai, Yu-Ching Wen et al. (6 authors)
The Aging Male
Published: Jul 2018
7 citations
7 citations
2265 days before retraction
Oral antidiyabetik metforminin hepatosellüler kanser hücreleri üzerine etkisi
Ayla Solmaz Avcıkurt, Eren Altun
Çukurova medical journal (Online)/Çukurova medical journal
Open Access
Published: May 2018
2348 days before retraction
Insulin glargine affects the expression of Igf-1r, Insr, and Igf-1 genes in colon and liver of diabetic rats.
Clara Ibet Juárez-Vázquez, Carmen Magdalena Gurrola‐Díaz, Belinda Vargas‐Guerrero et al. (9 authors)
DOAJ (DOAJ: Directory of Open Access Journals)
Published: May 2018
3 citations
3 citations
2353 days before retraction
Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia
Congyun Xu, Yan Xu, Zhou Shen et al. (6 authors)
International Urology and Nephrology
Published: Feb 2018
13 citations
13 citations
2424 days before retraction
Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?
Zongwei Wang, Aria F. Olumi
AJP Renal Physiology
Open Access
Published: Dec 2017
6 citations
6 citations
2499 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #64889
Dec 12, 2023Quick Stats
Total Citations:
27
Years Since Retraction:
1.1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025